✦ LIBER ✦

564 POSTER First-in-human (FIH) study of PF-00299804 in advanced cancer patients: correlation between pharmacokinetics (PK) and pharmacodynamics (PD)

✍ Scribed by J. Schellens; F. Guo; P.A. Jänne; S.G. Eckhardt; D.R. Camidge; I. Taylor; J. Lucca; D.S. Boss; S.G. Wong; C.D. Britten

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

135 A clinical phase I dose escalation,

✍ K. Mross; F. Baas; M. Medinger; J. Drevs; R. Strecker; J. Hennig; M. Wolters; G. 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 148 KB

365 First-in-human, safety, pharmacodyna

✍ J.C. Soria; U. Banerji; R. Bahleda; M. Martinez Garcia; S. Dolly; L. Lee; R. Rue 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 63 KB

580 First-in-human, Safety, Pharmacokine

✍ Dienstmann, R.; Lassen, U.; Cebon, J.; Desai, J.; Brown, M.P.; Evers, S.; Su, F. 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 75 KB

554 POSTER Pharmacokinetic (PK) and phar

✍ M.L. Rothenberg; E. Poplin; P. LoRusso; E. Yu; J. Schwartz; F. Fox; J. Mehnert; 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 73 KB

346 POSTER CBP501, a novel cell cycle G2

✍ M.S. Gordon; J.P. Eder; D.S. Mendelson; E. Wasserman; W. Sutherland; T. Kawabe; 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 58 KB

3553 POSTER Phase I/II study of S-1 in p

✍ J. Furuse; T. Okusaka; H. Ishii; K. Nakachi; E. Suzuki; S. Shimizu; H. Ueno; M. 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 57 KB